Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention

Author's Avatar
May 23, 2023

Pamela Bush, Chief Business Officer of Predictive Oncology, to discuss advancing pipelines and using patient heterogeneity with AI to solve the missing link in drug discovery